Fraport has received IATA CEIV Pharma recertification for its operations at Frankfurt Airport, after it having initially achieved the award in 2018.
IATA CEIV Pharma certification is recognition that a company conforms to IATA’s globally recognised pharma handling procedures and standards, and is capable of the "exemplary handling of time-critical and temperature-sensitive pharmaceutical goods".
Fraport said the recertification audit was carried out virtually due to Covid-19 restrictions.
Fraport’s head of ground services, Siegfried Pasler, explained: “The circumstances for the recertification were unusual for everyone involved. But thanks to the excellent preparatory work, we were able to give the auditor a realistic look at our processes.”
He added: “Securing recertification underscores the strong performance and reliability of our processes, equipment and systems deployed for handling sensitive pharmaceutical products. This CEIV recognition also encourages our dedicated handling teams during these challenging times and further strengthens Frankfurt Airport’s position as Europe’s leading pharma hub.
“During the coronavirus pandemic, we have clearly demonstrated the vital role that airfreight plays in supplying the world’s population. Frankfurt Airport also serves as a key partner in the distribution of vaccines, by delivering reliable services such as the seamless transport of vaccines on our airport ramp.”
